N-saccharinopentyl-benzylamino-cpd8b

human acetylcholinesterase inhibitor (IC50 = 33 nM) and beta amyloid aggregation inhibitor

General

Type : Alkyl linked bis-ligand, Sulfur Compound, Thiazole, Benzothiazol, Derivative of Saccharin, Multitarget, anti-Abeta-aggregation

Chemical_Nomenclature : 2-[5-(benzylamino)pentyl]-1,1-dioxo-1,2-benzothiazol-3-one

Canonical SMILES : C1=CC=C(C=C1)CNCCCCCN2C(=O)C3=CC=CC=C3S2(=O)=O

InChI : InChI=1S\/C19H22N2O3S\/c22-19-17-11-5-6-12-18(17)25(23,24)21(19)14-8-2-7-13-20-15-16-9-3-1-4-10-16\/h1,3-6,9-12,20H,2,7-8,13-15H2

InChIKey : ZGHYKEDJXGZSTQ-UHFFFAOYSA-N

Other name(s) : Compound 8b  ||  CHEMBL3922423  ||  BDBM50210827


MW : 358.5

Formula : C19H22N2O3S

CAS_number :

PubChem : 134140017

UniChem : ZGHYKEDJXGZSTQ-UHFFFAOYSA-N

Target

Families : N-saccharinopentyl-benzylamino-cpd8b ligand of proteins in family
ACHE

Protein :
human-ACHE

References (1)

Title : Multiple Ligands Targeting Cholinesterases and beta-Amyloid: Synthesis, Biological Evaluation of Heterodimeric Compounds with Benzylamine Pharmacophore - Szalaj_2015_Arch.Pharm.(Weinheim)_348_556
Author(s) : Szalaj N , Bajda M , Dudek K , Brus B , Gobec S , Malawska B
Ref : Arch Pharm (Weinheim) , 348 :556 , 2015
Abstract :
PubMedSearch : Szalaj_2015_Arch.Pharm.(Weinheim)_348_556
PubMedID: 26032855